Lupus & Connective Tissue Diseases
Guidelines
Updated EULAR recommendations for AAV include new drugs, practices
Avacopan and mepolizumab feature in new European recommendations for managing antineutrophil cytoplasmic antibody–associated vasculitis.
Feature
Abortion debate may affect Rx decisions for pregnant women
Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their...
Guidelines
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Recap
Expanded Treatment Options for Lupus Nephritis
Dr Joan Merrill discusses standard of care for patients with lupus nephritis and how recently approved agents belimumab and voclosporin have...
Conference Coverage
Lupus may lead to worse stroke outcomes for women, but not men
Women with systemic lupus erythematosus (SLE) were 20% more likely to have a prolonged hospital stay and 28% less likely to have a routine home...
From the Journals
Children with RMDs not at high risk for severe COVID-19, study finds
“Many parents and families with children who have RMDs have lived with great fear over the pandemic about whether or not their children are at an...
Conference Coverage
COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that...
Guidelines
Updated perioperative guidance says when to hold antirheumatics
Rheumatologists and orthopedic surgeons revise advice on JAK inhibitors and add new medications.
Guidelines
EULAR CVD management guidance focuses on gout, lupus, vasculitis
The recommendations advise on managing cardiovascular health in patients with gout, vasculitis, systemic sclerosis, myositis, Sjögren syndrome,...
From the Journals
New ivermectin, HCQ scripts highest in GOP-dominated counties
Rates of new hydroxychloroquine (HCQ) prescriptions particularly increased in highly Republican counties after the Food and Drug Administration...
Conference Coverage
Patients are interrupting DMARD use well into the COVID-19 pandemic
Rates of patients stopping disease-modifying antirheumatic drugs (DMARDs) have begun to rise after initially falling during the pandemic, with...